Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05667090

Effects of Multiple Mega-dose of Vitamin D3 Supplementation on Ameliorating Moderate to Severe Chronic Pain in Hemodialysis Patients

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Taipei Medical University Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

Pain is a major complaint in hemodialysis (HD) patients. Concentrations of parathyroid hormone (PTH) \>250 pg/ml are associated with chronic pain. Visual Analogue Scale (VAS) score which is used to assess the pain severity is positively related to PTH levels. This study is aimed to assess the effects of multiple mega dosages vitamin D supplementations in HD patients with chronic pain. It's a single-center, parallel, double-blind randomized control trial that administrations of 576,000 IU once a week of vitamin D3 for 4 weeks or placebo are for 120 eligible subjects. VAS and laboratory tests including serum concentrations of 25(OH)D, calcium, phosphorus, PTH and C-reactive protein will be evaluated.

Conditions

Interventions

TypeNameDescription
OTHERVitamin DOral supplementaiton of 576,000 IU once a week of vitamin D3 for 4 weeks
OTHERPlaceboOral supplementaiton of placebo once a week for 4 weeks

Timeline

Start date
2023-03-15
Primary completion
2025-12-31
Completion
2027-12-31
First posted
2022-12-28
Last updated
2023-03-30

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05667090. Inclusion in this directory is not an endorsement.